FROV30 (FROV30)

WOW...just saw the eod Level II .WTF happened.
A high of .0037 million bought.

Even more reason to transfer full Adderall rights to Elite . Methadone and Ropinirole alone ain’t gonna get us anywhere near the growth we need in the near term.

Also, #3 - should Elite sell or transfer ANDA…

It seems like Elite can amend the existing filing from a P IV to a P III if I’m reading the document correctly. So still, doesn’t make sense. Let us get the approval whenever and we’ll wait to launch as soon as those patents are up (assuming no one else has exclusivity).

Elite's attorneys are regarded, just like it's CEO.

We ain't launching Oxy until late 2028..........AT BEST.

I read that as submission to the FDA as in it buys Purdue even more time beyond the patent expiration date. 

It’s far from going to no bid. Bid is high AF right now and not something you see daily around the OTC market. 

Something is brewing and this is for sure going places (bid still gives the biggest tells)…I just don’t think it’s going be that big of a deal, anymore, after this crap.

Also, look at the past six Months. They had 7.5 - 1 Billion volume days over the past six Months. Backlog, bottleneck....fucked.

Does this mean every penny spent on this case was a complete waste of time since we can't launch until the patents are up?

Or in other words, we got absolutely nothing out of it, except losing money on attorney fees?

So Elite failed?

Thanks.

BIG IPO TOMORROW. Real company on major exchange. Excitement enthusiasm, whole world watching. Will be setting a benchmark for all  going forward. Not some pink sheet (FNMA) wanna be has been in conservatorship with total profit sweep waiting for a hand out . Most can recognize the difference. I am

The 200 = Wow
https://schrts.co/CWanBemw

https://investorshub.advfn.com/uimage/uploads/2026/6/12/pynusbag_june_11_sweet_but_vol.jpg


https://investorshub.advfn.com/uimage/uploads/2026/6/12/dwwgnbag_june_11_snip_vol_nuts.jpg


https://i

Chad Williams, CEO of Honey Badger Silver Inc. | Rule Symposium 2026: Rick Rule interviews

https://youtu.be/zGol2-Jz7p8

Got Germanium and Tungsten?

Daily Chart
https://schrts.co/kbyFeMMu

That Weekly W% up and Sto down, while pinching OMFG spells KaBoom to me

Overall Market will be crazy tomorrow perfect timing... well see just dont see a better time then now

We have INDEED met the requirement of at least 10 likes.

Therefore, AS PROMISED, here are the documents (11 pages):

STIPULATION of Dismissal and Proposed Order Regarding Irrevocable Covenant Not to Come to Market by ELITE LABORATORIES, INC., ELITE PHARMACEUTICALS, INC.

That’s great insight. Thanks for sharing. At least 14 months away from launch and going into final stages of FDA decision. Wonder where Accord is in the process.

OPFI

The thing I really love about OPFI is this acquisition I believe this will be a game changer to profitability with a combo of product and geographic diversification, combined with a lower cost of funds. I simply think this acquisition going forward will be a strong tailwind to th

What’s another 20 years to see .50 again.

Dead money lies here. Invest in VOO and you’ll come out much farther ahead. This is a terrible investment that will not pay off for a century at this point.

Voo and chill people. Why park money in a dead stock that won’t see a 2

Now let’s see if the Lowenstein clown shows back up on this board anytime soon. Then there will be no doubt whatsoever that they were involved in this case. Lmao.

Yesterday’s FINRA short volume ratio came in at 45.35% on ~40M total volume. Almost half of the shares traded yesterday were short sales even with reg sho in effect.

Could go lower. We'll see.
Will we get a Friday slam? Market has not yet digested what I believe to be good new

I wonder who dumped the million shares today and who picked them up? 🤔 $TMMI

INTU

I don't know where your coming up with these numbers but they are just not right in my opinion.

The adjusted tax rate through 9 months ended was 24% roughly for both years.

Pretax income for FY 26 non gaap is roughly 14.4% for nine months ended so f

Once again a personal attack. You are predictable. Yes I said that if their CFO is given the power to control spending and capital projects then KULR could become viable. They have lacked discipline for years. They can’t continue burning through millions of dollars with minimal results..

Just bought the stipulation document off Pacer, cost me slightly over 3 ELTP shares at current price. Lol. Looks like they both agreed to drop the case and as part of that, Elite agreed to not market OxyContin until the patents in this case expire, which this document says “the Asserted Patents all

I used to think Goldman Sachs would be the pick, now I am suspect ing CITI as Goldman Sachs have their hands all over on a couple of mega AI IPOs.